Found 0 matching trials
Ipilimumab and GMCSF Immunotherapy for Prostate Cancer
PHASE2This is an open-label randomized phase II study. Patients are randomized so...
Location
University of California
Cetuximab β Combined With PRaG Regimen in the Treatment of EGFR-positive Advanced Refractory Solid Tumors
PHASE2This study is a single-arm, multi-center, prospective clinical study aimed ...
Location
The Second Affiliated Hospital of Soochow University
A Study of ARRY-382 in Patients With Selected Advanced or Metastatic Cancers
PHASE1This is a Phase 1 study during which patients with advanced cancer will rec...
Location
Sarah Cannon Research Institute
Suicide Plus Immune Gene Therapy for Advanced Melanoma
EARLY_PHASE1Safety evaluation of combined immunogene therapy in patients with advanced ...
Location
Hospital Italiano
Vaccine Biotherapy of Cancer: Autologous Tumor Cells and Dendritic Cells
PHASE2This protocol was conducted as a single institution trial at Hoag Cancer Ce...
Location
Hoag Memorial Hospital Presbyterian
Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Healthy Adult Subjects
PHASE1TJ003234RAR101 is a first-in-human (FIH), single-center, randomized, double...
Humanized Monoclonal Antibody 3F8 (Hu3F8) With Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in the Treatment of Recurrent Osteosarcoma
PHASE2The purpose of this study is to find out what effect an antibody called Hum...
Status
Active Not Recruiting
Location
Children's Hospital of Los Angeles (Data Collection Only)
MCS110 With BRAF/MEK Inhibition in Patients With Melanoma
PHASE1This research study is studying a combination of targeted therapies as a po...
Location
Dana Farber Cancer Institute
Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma
PHASE2Background:
The mainstay of therapy for newly diagnosed multiple myeloma p...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Clinical Study for the Safety and Therapeutic Efficacy of the AI-QMMM Designed TamavaqTM Personalised Vaccine in Patients With Newly Diagnosed Glioma.
EARLY_PHASE1Gliomas are a heterogeneous group of tumors arising from glial cells in the...
Location
Biogenea Pharmaceuticals Ltd